@ARTICLE{
author={Djurmez Ognjen,Calamac Marina D,Dimitrijevic M,Serovic Katarina,Minic Ivana Z,Oblakovic-Babic Jelena S,Tomasevic Zoran M,Bozovic-Spasojevic Ivana M},
year={2021},
title={Vaccination against SARS-CoV-2 infection in patients with solid tumors: Experience from Institute for Oncology and Radiology of Serbia (IORS)},
journal={ANNALS OF ONCOLOGY},
volume={32},
number={},
pages={S1145-S1145},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Dimitrijevic M,Calamac Marina D,Djurmez Ognjen,Serovic Kristina,Minic Ivana Z,Oblakovic Jelena S,Tomasevic Zoran M,Bozovic-Spasojevic Ivana M},
year={2021},
title={Tolerability of luteinising hormone releasing hormoneanalogue (LHRH) therapy in patients with early breast cancer treatedat the Institute for Oncology and Radiology of Serbia (IORS)},
journal={BREAST},
volume={56},
number={},
pages={S89-S89},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Djurmez Ognjen,Calamac Marina D,Dimitrijevic M,Serovic Kristina,Oblakovic-Babic Jelena S,Minic Ivana Z,Tomasevic Zoran M,Bozovic-Spasojevic Ivana M},
year={2021},
title={Our experience with COVID-19 infection in oncology patients},
journal={BREAST},
volume={56},
number={},
pages={S89-S89},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Calamac Marina D,Minic Ivana Z,Tomasevic Zoran M,Oblakovic-Babic Jelena S,Serovic Kristina,Djurmez Ognjen,Dimitrijevic M,Bozovic-Spasojevic Ivana M},
year={2021},
title={Long-term trastuzumab treatment in HER2 positive metastatic breast cancer},
journal={BREAST},
volume={56},
number={},
pages={S82-S83},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Tomasevic Zoran M,Grujicic Danica M,Nikitovic Marina R,Milovanovic Zorka M},
year={2020},
title={Incidence of non-breast cancer neoplasms (non-BCN) diagnosed prior and subsequent to breast cancer (BC): Single institution experience.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={38},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Todorovic Vladimir,...,Babovic Nada Lj,...,Cetnikovic Bojana,Ceric Timur,...,Dzamic Zoran M,Dzodic Radan R,Eri Zivka,...,Knezevic-Usaj Slavica F,Kovcin Vladimir N,...,Markovic Ivan Z,Markovic Milan,Mijalkovic Nenad,...,Pantelic Aleksandra,Popovic Lazar S,Radosavljevic Davorin Z,...,Radulovic Sinisa S,...,Rosic Ivana,...,Stamatovic Ljiljana,...,Tesanovic Dusanka D,Tomasevic Zorica I,Tomasevic Zoran M,...,Vasovic Suzana,Vicko Ferenc,...,Zaric Bojan,...,(broj koautora 65)},
year={2019},
title={AROME-ESO Oncology Consensus Conference: access to cancer care innovations in countries with limited resources. Association of Radiotherapy and Oncology of the Mediterranean Area (AROME-Paris) and European School of Oncology (ESO - Milan)},
journal={JOURNAL OF BUON},
volume={24},
number={5},
pages={2180-2197},
document_type={Article},
} 

@ARTICLE{
author={Kolberg Hans-Christian,Colleoni Marco A,Tomasevic Zoran M,Ponomarova O,McBride HJ,Tesch Hans,Hanes Vladimir},
year={2019},
title={Matching the critical function of the biosimilar ABP 980 and trastuzumab: Totality of evidence and scientific justification for extrapolation across trastuzumab indications},
journal={CANCER RESEARCH},
volume={79},
number={4},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Smyth LM,Saura C,Boni V,Garcia-Saenz JA,Prat A,Eli L,Garza SJ,Lalani AS,Crown JP},
year={2019},
title={HER-Seq: A blood-based genomic screening study to identify HER2 mutation-positive patients for enrollment into clinical trials with the pan-HER inhibitor neratinib},
journal={ANNALS OF ONCOLOGY},
volume={30},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kolberg Hans-Christian,Tomasevic Zoran M,Demetriou Georgia S,von Minckwitz Gunter,Fujiwara Yasuhiro,Ponomarova O,Tesch Hans,Santi Patricia Xavier,Hanes Vladimir},
year={2018},
title={Clinical comparison of the biosimilar ABP 980 and trastuzumab in early breast cancer: Results of the phase 3 LILAC study and justification for extrapolation across approved trastuzumab indications},
journal={EUROPEAN JOURNAL OF CANCER},
volume={92},
number={},
pages={S103-S104},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Serovic Kristina,Tomasevic Zoran M,Bozovic-Spasojevic Ivana M,Minic Ivana Z,Oblakovic-Babic Jelena S,Jokic Vladimir,Pusica Aleksandra,Tomasevic Zorica I},
year={2018},
title={Paclitaxel-induced peripheral neuropathy in patients with operable breast cancer},
journal={EUROPEAN JOURNAL OF CANCER},
volume={92},
number={},
pages={S54-S54},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Jimenez Martin M,...,Tomasevic Zoran M,...,(broj koautora 20)},
year={2017},
title={Neratinib after trastuzumab (T)-based adjuvant therapy in early-stage HER2+breast cancer (BC): 5-year analysis of the phase III ExteNET trial},
journal={ANNALS OF ONCOLOGY},
volume={28},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Tomasevic Zoran M,Bozovic-Spasojevic Ivana M,Serovic Kristina,Stojanovic Aleksandar,Zdrale Zdravko,Neric Dobrica,Kovac Zeljko},
year={2016},
title={Family and personal cancer history in young patients with pregnancy associated breast cancer.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={34},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Tomasevic Zorica I,Bozovic-Spasojevic Ivana M,Serovic Kristina,Stojanovic Aleksandar,Zdrale Zdravko},
year={2016},
title={Durable disease control in patients with metastatic breast cancer treated with single agent capecitabine.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={34},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Tomasevic Zorica I,Neric Dobrica,Milosevic Snezana,Bozovic-Spasojevic Ivana M,Zdrale Zdravko,Sarcevic Aleksandra,Kolarevic Daniela},
year={2015},
title={Durable Remissions with Trastuzumab Treatment for Her2 Positive Metastatic Breast Cancer - Single Center Experience},
journal={BREAST},
volume={24},
number={},
pages={S42-S42},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Tomasevic Zoran M,Kovac Zeljko,Milovanovic Zorka M,Minic Ivana Z,Milosevic Snezana,Bozovic-Spasojevic Ivana M,Zdrale Zdravko,Markovic Ivan Z,Dzodic Radan R},
year={2015},
title={Young patients with breast cancer: Comparison of molecular characteristics of pregnancy associated breast cancer with non-pregnancy associated breast cancer},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={33},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Milovanovic Zorka M,Tomasevic Zoran M,Bozovic-Spasojevic Ivana M,Milosevic Snezana,Zdrale Zdravko,Andjelic-Dekic Natasa,Kovac Zeljko},
year={2015},
title={Histology and molecular characteristics of pregnancy associated breast cancer},
journal={ANNALS OF ONCOLOGY},
volume={26},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Tomasevic Zoran M,Kovac Zeljko,Milovanovic Zorka M},
year={2014},
title={Breast cancer metastases to cerebellum},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={32},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Matic Ivana Z,Grujic M,Kolundzija Branka S,Damjanovic-Velickovic Ana,Tomasevic Zoran M,Bozovic-Spasojevic Ivana M,Dzodic Radan R,Zdrale Zdravko,Juranic Zorica D},
year={2014},
title={Changes of the white blood cells subsets in HER2 positive breast cancer patients treated with trastuzumab},
journal={EUROPEAN JOURNAL OF CANCER},
volume={50},
number={},
pages={S214-S214},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Tomasevic Zoran M,Kovac Zeljko,Milovanovic Zorka M},
year={2014},
title={Brain metastases as first metastatic site in HER2 positive breast cancer patients - prospective breast cancer brain metastases database evaluation},
journal={EUROPEAN JOURNAL OF CANCER},
volume={50},
number={},
pages={S78-S79},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Kovac Zeljko,Tomasevic Zoran M},
year={2013},
title={Characteristics of patients with prolonged survival after breast cancer brain metastases (BCBM).},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={31},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Kovac Zeljko,Tomasevic Zoran M,Milovanovic Zorka M},
year={2013},
title={PROLONGED SURVIVAL AFTER BREAST CANCER BRAIN METASTASES (BCBM): WHO HAS A CHANCE?},
journal={BREAST},
volume={22},
number={},
pages={S46-S47},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Milanovic Nenad,Ristic Dusan J,Puric Mila,Tomasevic Zoran M},
year={2013},
title={Ifosfamide, methotrexate, and etoposide (IMVP) as a salvage therapy for transplant-ineligible aggressive non-Hodgkin lymphoma patients - long term surveillance},
journal={EUROPEAN JOURNAL OF CANCER},
volume={49},
number={},
pages={S854-S854},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Gavrilovic Dusica,Tomasevic Zoran M,Kolarevic Daniela},
year={2012},
title={Concordance of histology type between synchronous and metachronous contralateral breast carcinoma: Is there susceptibility for breast cancer of particular histology?},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={30},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Tomasevic Zorica I},
year={2012},
title={Impact of lower chemotherapy dose on treatment outcome and survival of patients with advanced Hodgkin lymphoma: Single institution experience.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={30},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Tomasevic Zorica I},
year={2012},
title={Impact of lower chemotherapy dose on treatment outcome and survival of patients with advanced Hodgkin lymphoma: Single institution experience.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={30},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Tomasevic Zoran M,Kolarevic Daniela,Milovanovic Zorka M},
year={2012},
title={Histology of Synchronous and Metachronous Contra-Lateral Breast Carcinoma},
journal={ANNALS OF ONCOLOGY},
volume={23},
number={},
pages={544-545},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Rakocevic Z,Tomasevic Zoran M,Milovanovic Zorka M,Inic Momcilo M,Kolarevic Daniela,Lukic Vesna,Kovac Zeljko},
year={2012},
title={Incidence of brain metastases in early stage HER2 3+breast cancer patients; Is there a role for brain CT in asymptomatic patients?},
journal={JOURNAL OF BUON},
volume={17},
number={2},
pages={249-253},
document_type={Article},
} 

@ARTICLE{
author={Tomasevic Zoran M,Milovic Marijana M,Tomasevic Zoran M,Milovanovic Zorka M},
year={2012},
title={Breast Cancer Metastases to the Gynecological Organs and Peritoneum: a Single Institution Experience},
journal={ANNALS OF ONCOLOGY},
volume={23},
number={},
pages={48-48},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Kolarevic Daniela,Tomasevic Zoran M,Milovanovic Zorka M},
year={2012},
title={Breast Cancers as a Secondary Malignancy After Treatment for Hodgkin Lymphoma - Focus on HER2 Status},
journal={EUROPEAN JOURNAL OF CANCER},
volume={48},
number={},
pages={S62-S62},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kolarevic Daniela,Tomasevic Zoran M,Dzodic Radan R,Gavrilovic Dusica,Zegarac Milan},
year={2012},
title={Clinical and pathological response to induction chemotherapy used as a prognostic factor in inflammatory breast cancer. Single institution experience},
journal={JOURNAL OF BUON},
volume={17},
number={1},
pages={21-26},
document_type={Article},
} 

@ARTICLE{
author={Kolarevic Daniela,Tomasevic Zoran M},
year={2011},
title={Therapeutic response to induction chemotherapy and prognosis of patients with inflammatory breast cancer in respect to HER2 and hormonal status},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={29},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Kovac Zeljko,Milovanovic Zorka M,Gavrilovic Dusica},
year={2011},
title={The risk for brain metastases in HER2 3+BC five years after primary BC diagnosis},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={29},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Kovac Zeljko,Milovanovic Zorka M},
year={2011},
title={Influence of Breast Cancer Molecular Parameters on Median Time to Brain Metastases},
journal={ANNALS OF ONCOLOGY},
volume={22},
number={},
pages={63-63},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Nikolic Srdjan S,Tomasevic Zoran M,Inic Momcilo M,Zegarac Milan,Pupic Gordana S},
year={2010},
title={Resection of Breast Cancer Liver Metastases: Single Institution Experience},
journal={CANCER RESEARCH},
volume={70},
number={},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Milovanovic Zorka M,Tomasevic Zoran M,Skender Milica K,Pupic Gordana S,Kovac Zeljko,Grujicic Danica M},
year={2010},
title={Comparison of hormone receptor and HER2 status in resected brain metastases and primary breast cancer.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={28},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Kolarevic Daniela,Tomasevic Zoran M,Milovanovic Zorka M},
year={2010},
title={HER2 status of breast carcinoma developed as a secondary malignancy after Hodgkin lymphoma treatment},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={28},
number={15},
pages={-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Ristic Dusan J,Tomasevic Zorica I,Borojevic Nenad D,Jelic Svetislav B},
year={2010},
title={Aggressive Fibromatosis Treated with Combination of Cvp and Tamoxifen: a Case Series Update Analysis},
journal={ANNALS OF ONCOLOGY},
volume={21},
number={},
pages={415-415},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kolarevic Daniela,Tomasevic Zoran M,Borojevic Nenad D,Jelic Svetislav B},
year={2010},
title={CHARACTERISTICS OF INFLAMMATORY BREAST CANCER PATIENTS WHO FAILED TO SHOW RESPONSE TO INDUCTION CHEMOTHERAPY},
journal={ANNALS OF ONCOLOGY},
volume={21},
number={},
pages={116-116},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Kovac Zeljko,Tomasevic Zoran M,Milovanovic Zorka M},
year={2010},
title={COMPARISON OF MEDIAN TIME TO BRAIN METASTASES DEVELOPMENT IN TRIPLE NEGATIVE BC AND HER2 3+BC},
journal={ANNALS OF ONCOLOGY},
volume={21},
number={},
pages={113-114},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Vasovic Suzana,Stamatovic Ljiljana,Tomasevic Zoran M,Karaferic Andjela,Pavlovic L,Karadzic Katarina,Jovanic Irena P},
year={2010},
title={EVALUATION OF PROGNOSTIC VALUE OF HER2 AND VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) EXPRESSION FOR PREDICTING EARLY FAILURE IN PATIENTS WITH OPERABLE BREAST CANCER},
journal={ANNALS OF ONCOLOGY},
volume={21},
number={},
pages={90-90},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Nikolic Vladimir,Tomasevic Zoran M,Radosavljevic Davorin Z,Nikolic Vladimir,Jovanovic Julija V},
year={2010},
title={Bevacizumab Plus Chemotherapy in Treating Liver Metastasis of MCRC: Is There a Difference Between Gender?},
journal={ANNALS OF ONCOLOGY},
volume={21},
number={},
pages={113-114},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Stanojevic Boban R,Dzodic Radan R,Saenko Vladimir,Milovanovic Zorka M,Pupic Gordana S,Zivkovic Ognjen,Markovic Ivan Z,Djurisic Igor,Buta Marko N,Tomasevic Zoran M,Rogounovitch Tatiana,Mitsutake Norito,Mine Mariko,Shibata Yoshisada,Yamashita Shunichi},
year={2010},
title={Mutational and clinicopathological analysis of papillary thyroid carcinoma in Serbian patients},
journal={ENDOCRINE JOURNAL},
volume={57},
number={},
pages={S451-S451},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Nikolic Srdjan S,Inic Momcilo M,Jevric Marko,Zegarac Milan,Milovanovic Zorka M,Pupic Gordana S,Tomasevic Zoran M,Martinovic Aleksandar},
year={2010},
title={Breast Cancer Metastases in the Liver and Lungs: to Resect Or Not to Resect?},
journal={ANNALS OF ONCOLOGY},
volume={21},
number={},
pages={59P-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kolarevic Daniela,Tomasevic Zoran M,Jelic Svetislav B},
year={2010},
title={Response Rate to Induction Anthracycline-based Chemotherapy in Inflammatory Breast Carcinoma},
journal={ANNALS OF ONCOLOGY},
volume={21},
number={},
pages={58P-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Kolarevic Daniela,Tomasevic Zoran M,Jelic Svetislav B},
year={2010},
title={Synchronous and metachronous bilateral breast cancer: one or two entities?},
journal={EJC SUPPLEMENTS},
volume={8},
number={3},
pages={194-195},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Rakocevic Z,Tomasevic Zoran M,Milosevic Snezana,Kolarevic Daniela,Lukic Vesna,Kovac Zeljko,Susnjar Snezana V,Inic Momcilo M,Borojevic Nenad D},
year={2010},
title={Incidence of brain metastases in early stage high risk Her2 3+breast cancer patients},
journal={EJC SUPPLEMENTS},
volume={8},
number={3},
pages={72-72},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Radosevic-Jelic Ljiljana M,Tomasevic Zoran M,Jelic Svetislav B,Milovanovic Zorka M},
year={2009},
title={Late relapse in triple negative breast cancer},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={27},
number={15},
pages={e12022-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Nikolic NM,Tomasevic Zoran M,Jelic Svetislav B},
year={2009},
title={Secondary malignancies developing during metastatic breast cancer treatment},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={27},
number={15},
pages={e12020-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Nikolic Srdjan S,Jevric Marko,Pupic Gordana S,Milovanovic Zorka M,Skender Milica K,Inic Momcilo M,Tomasevic Zoran M,Djodic R,Zegarac Milan,Vasovic Suzana,Jelic Svetislav B},
year={2009},
title={Comparison between Steroid Receptors and Her2 Status in Primary Breast Carcinoma and Completely Resected Breast Carcinoma Metastases from Different Visceral Organ Sites},
journal={CANCER RESEARCH},
volume={69},
number={24},
pages={722S-723S},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Milovanovic Zorka M,Kovac Zeljko,Vasovic Suzana,Susnjar Snezana V},
year={2009},
title={Breast cancer brain metastases - significant differences in biological markers in early vs. late relapse},
journal={EJC SUPPLEMENTS},
volume={7},
number={2},
pages={290-291},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Radosevic-Jelic Ljiljana M,Jovanovic Danica,Milovanovic Zorka M,Tomasevic Zoran M,Jezdic Svetlana D,Borojevic Nenad D},
year={2009},
title={Brain metastases as late breast cancer relapse. Single institution experience and review of the literature},
journal={JOURNAL OF BUON},
volume={14},
number={2},
pages={225-228},
document_type={Article},
} 

@ARTICLE{
author={Tomasevic Zoran M,Radosevic-Jelic Ljiljana M,Tomasevic Zoran M,Milovanovic Zorka M,Jelic Svetislav B},
year={2009},
title={DOES HER2 STATUS OF THE PRIMARY BREAST CANCERS INFLUENCE TIME TO LATE RELAPSE?},
journal={ANNALS OF ONCOLOGY},
volume={20},
number={},
pages={50-51},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Stamatovic Ljiljana,Vasovic Suzana,Karaferic Andjela,Tomasevic Zoran M,Jelic Svetislav B},
year={2008},
title={Capecitabine In Cisplatin-Pretreated Metastatic Or Recurrent Squamous Cell Carcinoma of The Cervix: A Possible Therapy Option For Obtaining Clinically Meaningful Outcome?},
journal={ANNALS OF ONCOLOGY},
volume={19},
number={},
pages={214-214},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Rakocevic Z,Milosevic Snezana,Tomasevic Zorica I},
year={2008},
title={Brain Metastases During Adjuvant Trastuzumab Treatment},
journal={ANNALS OF ONCOLOGY},
volume={19},
number={},
pages={87-87},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Nikolic Vladimir,Jelic Svetislav B,Tomasevic Zoran M},
year={2008},
title={Second non-breast malignancies in patients treated for breast carcinoma},
journal={ANNALS OF ONCOLOGY},
volume={19},
number={},
pages={138-138},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zorica I,Jovanovic Danica,Radosevic-Jelic Ljiljana M,Tomasevic Zoran M,Vasovic Suzana,Stamatovic Ljiljana,Jelic Svetislav B,Spasic Jelena R},
year={2006},
title={HER-2 status of the primary breast cancer in patients with late disease relapse},
journal={ANNALS OF ONCOLOGY},
volume={17},
number={},
pages={89-89},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Nikolic-Tomasevic Zorica I,Jelic Svetislav B,Cassidy Jonathan,Filipovic-Ljeskovic Ivana M,Tomasevic Zoran M},
year={2005},
title={Fluoropyrimidine therapy: hyperbilirubinemia as a consequence of hemolysis},
journal={CANCER CHEMOTHERAPY AND PHARMACOLOGY},
volume={56},
number={6},
pages={594-602},
document_type={Article},
} 

@ARTICLE{
author={Nikolic-Tomasevic Zorica I,Jelic Svetislav B,Tomasevic Zoran M,Radulovic Sinisa S,Radosavljevic Davorin Z,Popov Ivan P},
year={2005},
title={Lower than standard doses of irinotecan (cpt-11) in the treatment of metastatic colorectal carcinoma (MCC)},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={23},
number={16},
pages={305S-305S},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Popov Ivan P,Josifovski Jeremija J,Tomasevic Zoran M,Babic Dragana,Jelic Svetislav B},
year={2005},
title={Incomplete liver resection plus chemotherapy in patients with metastatic colorectal cancer (CRC) decrease survival in comparison to chemotherapy alone},
journal={ANNALS OF ONCOLOGY},
volume={16},
number={},
pages={286-286},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Tomasevic Zoran M,Ristic Dusan J},
year={2004},
title={Therapy of aggressive fibromatosis is still an open question: A series of patients treated at a single institution.},
journal={JOURNAL OF CLINICAL ONCOLOGY},
volume={22},
number={14},
pages={9060-},
document_type={Meeting Abstract},
} 

@ARTICLE{
author={Suvajdzic Nada D,Stojanovic-Milenkovic Roksanda,Tomasevic Zoran M,Cemerikic-Martinovic Vesna M,Mihaljevic Biljana S,Atkinson Henry DE},
year={2003},
title={ALK-negative T-cell anaplastic large cell lymphoma associated with systemic lupus erythematosus},
journal={MEDICAL ONCOLOGY},
volume={20},
number={4},
pages={409-412},
document_type={Editorial Material},
} 

@ARTICLE{
author={Jelic Svetislav B,Babovic Nada Lj,Kreacic Miroslav,Matkovic Suzana V,Milanovic Nenad,Gavrilovic Dusica,Tomasevic Zoran M},
year={1999},
title={Epirubicin 150 mg/m(2)-cisplatin versus epirubicin 180 mg/m(2)-cisplatin for advanced soft tissue sarcoma},
journal={INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY RESEARCH},
volume={19},
number={4},
pages={129-138},
document_type={Article},
}